Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT01520844

the ANRS CO21 " Extreme " Cohort (CODEX)

Led by ANRS, Emerging Infectious Diseases · Updated on 2026-04-07

450

Participants Needed

1

Research Sites

969 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A consortium of research teams has studied the immunovirological characteristics of these patients: The ANRS CO15 ALT cohort The ANRS CO18 HIV Controller cohort the ANRS EP47 VISCONTI study

CONDITIONS

Official Title

the ANRS CO21 " Extreme " Cohort (CODEX)

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient infected with HIV-1 and not co-infected with HIV-2
  • Age 18 years or older at enrollment
  • Able to give written consent
  • Covered by French Social Security
  • Accept the constraints imposed by the study
  • Without antiretroviral therapy for ALT, HIC, and ALT HIC groups; control of viral load after antiretroviral treatment interruption in PTC group
  • ALT group: HIV-1 positive for at least 8 years with CD4 count above 600/mm3 and stable or increasing over last 5 years without antiretroviral treatment
  • HIC group: HIV-1 positive for at least 5 years, asymptomatic, with last 5 viral loads below 400 copies/mL without antiretroviral treatment
  • ALT HIC group: HIV-1 positive for at least 8 years with stable or increasing CD4 counts and last 5 viral loads below 400 copies/mL without antiretroviral therapy
  • PTC group: Started antiretroviral therapy during primary or chronic infection, treated for at least 12 months, with viral loads below 400 copies/mL for 12 months or more after stopping therapy, allowing for one viral load blip
Not Eligible

You will not qualify if you...

  • Under protection (saving) of justice

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lambotte

Le Kremlin-Bicêtre, France

Actively Recruiting

Loading map...

Research Team

O

Olivier Lambotte, Professor

CONTACT

F

Faroudy Boufassa

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here